141 related articles for article (PubMed ID: 26339553)
1. A novel biomechanical analysis of gait changes in the MPTP mouse model of Parkinson's disease.
Geldenhuys WJ; Guseman TL; Pienaar IS; Dluzen DE; Young JW
PeerJ; 2015; 3():e1175. PubMed ID: 26339553
[TBL] [Abstract][Full Text] [Related]
2. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
[TBL] [Abstract][Full Text] [Related]
3. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
Sconce MD; Churchill MJ; Greene RE; Meshul CK
Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
[TBL] [Abstract][Full Text] [Related]
4. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
5. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
Choi JG; Huh E; Ju IG; Kim N; Yun J; Oh MS
J Neurol Sci; 2018 Sep; 392():77-82. PubMed ID: 30031172
[TBL] [Abstract][Full Text] [Related]
6. Selegiline rescues gait deficits and the loss of dopaminergic neurons in a subacute MPTP mouse model of Parkinson's disease.
Zhao Q; Cai D; Bai Y
Int J Mol Med; 2013 Oct; 32(4):883-91. PubMed ID: 23877198
[TBL] [Abstract][Full Text] [Related]
7. Vertical grid test and modified horizontal grid test are sensitive methods for evaluating motor dysfunctions in the MPTP mouse model of Parkinson's disease.
Kim ST; Son HJ; Choi JH; Ji IJ; Hwang O
Brain Res; 2010 Jan; 1306():176-83. PubMed ID: 19804765
[TBL] [Abstract][Full Text] [Related]
8. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
[TBL] [Abstract][Full Text] [Related]
9. Impaired CBS-H
Yuan YQ; Wang YL; Yuan BS; Yuan X; Hou XO; Bian JS; Liu CF; Hu LF
Brain Behav Immun; 2018 Jan; 67():77-90. PubMed ID: 28774789
[TBL] [Abstract][Full Text] [Related]
10. The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
Gratuze M; Josset N; Petry FR; Pflieger M; Eyoum Jong L; Truchetti G; Poitras I; Julien J; Bezeau F; Morin F; Samadi P; Cicchetti F; Bretzner F; Planel E
Brain Res; 2019 May; 1711():106-114. PubMed ID: 30641037
[TBL] [Abstract][Full Text] [Related]
11. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease.
Amende I; Kale A; McCue S; Glazier S; Morgan JP; Hampton TG
J Neuroeng Rehabil; 2005 Jul; 2():20. PubMed ID: 16042805
[TBL] [Abstract][Full Text] [Related]
12. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
13. Nicotine improved the olfactory impairment in MPTP-induced mouse model of Parkinson's disease.
Yang J; Lv DJ; Li LX; Wang YL; Qi D; Chen J; Mao CJ; Wang F; Liu Y; Hu LF; Liu CF
Neurotoxicology; 2019 Jul; 73():175-182. PubMed ID: 30978411
[TBL] [Abstract][Full Text] [Related]
14. Chronic and progressive Parkinson's disease MPTP model in adult and aged mice.
Muñoz-Manchado AB; Villadiego J; Romo-Madero S; Suárez-Luna N; Bermejo-Navas A; Rodríguez-Gómez JA; Garrido-Gil P; Labandeira-García JL; Echevarría M; López-Barneo J; Toledo-Aral JJ
J Neurochem; 2016 Jan; 136(2):373-87. PubMed ID: 26500044
[TBL] [Abstract][Full Text] [Related]
15. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson's disease.
Kim HG; Park G; Piao Y; Kang MS; Pak YK; Hong SP; Oh MS
Food Chem Toxicol; 2014 Mar; 65():293-300. PubMed ID: 24389454
[TBL] [Abstract][Full Text] [Related]
16. Connexin 30 deficiency attenuates A2 astrocyte responses and induces severe neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride Parkinson's disease animal model.
Fujita A; Yamaguchi H; Yamasaki R; Cui Y; Matsuoka Y; Yamada KI; Kira JI
J Neuroinflammation; 2018 Aug; 15(1):227. PubMed ID: 30103794
[TBL] [Abstract][Full Text] [Related]
17. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
19. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
20. Continuous MPTP intoxication in the Göttingen minipig results in chronic parkinsonian deficits.
Nielsen MS; Glud AN; Møller A; Mogensen P; Bender D; Sørensen JC; Doudet D; Bjarkam CR
Acta Neurobiol Exp (Wars); 2016; 76(3):199-211. PubMed ID: 27685773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
